Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

OBJECTIVE: To describe the course and predictors of glycemic control among patients with type 2 diabetes after sulfonylureas (SUs) are added to metformin (MF). RESEARCH DESIGN AND METHODS: Patients (n = 2,220) treated with MF monotherapy for >90 days before initiating MF plus SU combination...

Full description

Bibliographic Details
Main Authors:	Cook, M, Girman, C, Stein, P, Alexander, C, Holman, R
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
by: Hanefeld, M, et al.
Published: (2004)

Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
by: J Muthukrishnan, et al.
Published: (2012-01-01)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
by: Srivanichakorn W, et al.
Published: (2015-03-01)

Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
by: Gebrie D, et al.
Published: (2021-07-01)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
by: Wright, A, et al.
Published: (2006)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
by: Kunavisarut T, et al.
Published: (2019-05-01)

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
by: Yujin Shin, et al.
Published: (2020-06-01)

Comparison of inflammatory markers in type 2 diabetic patients treated with empagliflozin, metformin, and sulfonylurea
by: Pegah Mohaghegh, et al.
Published: (2023-10-01)

The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
by: Tri Murti Andayani,, et al.
Published: (2009-12-01)

Starting with low dose sulfonylurea and metformin in early stage type 2 diabetes mellitus
by: Joe George
Published: (2015-01-01)

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.
by: Fu-Shun Yen, et al.
Published: (2020-01-01)

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
by: Christina S. Kwon, et al.
Published: (2018-02-01)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
by: Zambanini Andrew, et al.
Published: (2008-04-01)

Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
by: Elis Susilawati, et al.
Published: (2023-08-01)

Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact
by: Antoni Sicras-Mainar, et al.
Published: (2014-12-01)

Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin
by: Peng X, et al.
Published: (2016-08-01)

Low branched chain amino acids and tyrosine in Thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies
by: Sriboonvorakul, N, et al.
Published: (2021)

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
by: Natthida Sriboonvorakul, et al.
Published: (2021-11-01)

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
by: Yu Mi Kang, et al.
Published: (2019-08-01)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
by: You-Cheol Hwang
Published: (2015-12-01)

DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
by: Eeley, E, et al.
Published: (1992)

Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017-03-01)

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
by: Desye Gebrie, et al.
Published: (2021-01-01)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
by: Zhou, K, et al.
Published: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
by: Zhou, K, et al.
Published: (2011)

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
by: Newby, D, et al.
Published: (2022)

Consensus recommendations on sulfonylurea & sulfonylurea combinations in the management of Type 2 diabetes mellitus - international task force
by: Sanjay Kalra, et al.
Published: (2019-01-01)

Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force
by: Sanjay Kalra, et al.
Published: (2018-01-01)

Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study
by: Wahlqvist Mark L, et al.
Published: (2012-11-01)

Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
by: Seung-Eun Lee, et al.
Published: (2019-08-01)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
by: Nicole Oosterom, et al.
Published: (2022-01-01)

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
by: Holman, R
Published: (2006)

Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
by: Ivan Sergeevich Kuznetsov, et al.
Published: (2013-09-01)

Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
by: Ivan Sergeevich Kuznetsov, et al.
Published: (2013-09-01)

Deterioration in glycemic control on schooldays among children and adolescents with type 1 diabetes: A continuous glucose monitoring-based study
by: Yu Ding, et al.
Published: (2022-12-01)